Europska Unija - hrvatski - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - piletina - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Europska Unija - hrvatski - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - piletina - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

gorea plus d.o.o. svetonedeljska cesta 97 10431 kerestinec -

Europska Unija - hrvatski - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - živi rekombinantni turkey herpes virus (rhvt / nd) povezan s stanicom, koji eksprimira fuzijski protein newcastle bolesti virusa d-26 lentogenog soja - imunomodulatori za aves živih virusnih cjepiva - chicken; embryonated eggs - za aktivne imunizacije 18 dana-starog эмбрионами kokošjih jaja ili dnevne pilića za smanjenje smrtnosti i kliničkih znakova, uzrokovane virusa Ньюкаслской bolesti i smanjiti smrtnost, klinički simptomi i lezije uzrokovane Марека bolesti zaraze s фенотипом "вирулентный".

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Europska Unija - hrvatski - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantel-stanica - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medic d.o.o. trg dražena petrovića 3 10000 zagreb -

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

doctum d.o.o. eugena kumičića 2 opatija -

Europska Unija - hrvatski - EMA (European Medicines Agency)

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - drugi gastrointestinalni trakt i metabolizam, lijekovi, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

roche d.o.o. ulica grada vukovara 269 a 10000 zagreb -